Desmoid Tumors Market Leading Desmoid Tumors companies include SpringWorks Therapeutics, Immunome / Ayala Pharmaceuticals, Iterion Therapeutics, Eisai, PRISM BioLab, MedPacto, Inc., Pfizer, Novartis, Aadi Bioscience, Inc., INSYS Therapeutics Inc, Recursion Pharmaceuticals Inc, among others actively engaged in advancing therapeutic innovation. … Continue reading →

Radiofrequency Ablation Devices Market DelveInsight’s New Report Reveals 11.16% CAGR Growth, Spotlighting AI Integration, Key Players, and Regional Dynamics Reshaping Global Radiofrequency Ablation DelveInsight Business Research LLP, a premier life sciences market research and consulting firm, today announced the release … Continue reading →

Aficamten Sales Market Aficamten’s growth is primarily driven by strong unmet need in symptomatic obstructive hypertrophic cardiomyopathy (oHCM), compelling Phase III efficacy data, and its next-generation cardiac myosin inhibition profile. Predictable pharmacokinetics, rapid reversibility, and simplified dosing position it for … Continue reading →

Eosinophilic Esophagitis Market Eosinophilic Esophagitis Companies are Ellodi Pharmaceuticals, AstraZeneca, Regeneron Pharmaceuticals, Sanofi, Bristol-Myers Squibb, Allakos, EsoCap AG, Pfizer, Ception Therapeutics, Celgene, Dr. Falk Pharma GmbH, Revolo Biotherapeutics, Shire, Novartis, EMS, Celgene, Oxagen Ltd, Meritage Pharma, Inc, Forest Laboratories, and … Continue reading →

Embolic Protection Devices Market Some of the key market players operating in the embolic protection devices market include Boston Scientific Corporation, Abbott, Medtronic, Cordis, Contego Medical, Inc., Integer Holdings Corporation, InspireMD Inc., Emboline, Inc., Keystone Heart Ltd., Lepu Medical Technology(Beijing) … Continue reading →